Publications by authors named "Inmaculada Monleon"

Claim this Profile
S
Safety, tolerability, immunogenicity, and efficacy of ABvac40 active immunotherapy against Aβ40 in patients with mild cognitive impairment or very mild Alzheimer's disease: A randomized, double-blind, placebo-controlled phase 2 study.
María Pascual-Lucas, Ana María Lacosta, María Montañés, Jesús Canudas, Jorge Loscos

Alzheimers Dement· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study.
Virginia Pérez-Grijalba, Javier Arbizu, Judith Romero, Elena Prieto, Pedro Pesini

Alzheimers Res Ther· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability and immunogenicity of an active anti-Aβ vaccine (ABvac40) in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase I trial.
Ana-María Lacosta, María Pascual-Lucas, Pedro Pesini, Diego Casabona, Virginia Pérez-Grijalba

Alzheimers Res Ther· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood amyloid beta levels in healthy, mild cognitive impairment and Alzheimer's disease individuals: replication of diastolic blood pressure correlations and analysis of critical covariates.
Agustín Ruiz, Pedro Pesini, Ana Espinosa, Virginia Pérez-Grijalba, Sergi Valero

PLoS One· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Several direct and calculated biomarkers from the amyloid-β pool in blood are associated with an increased likelihood of suffering from mild cognitive impairment.
Virginia Pérez-Grijalba, Pedro Pesini, Inmaculada Monleón, Mercè Boada, Lluís Tárraga

J Alzheimers Dis· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reliable Measurements of the β-Amyloid Pool in Blood Could Help in the Early Diagnosis of AD.
Pedro Pesini, Virginia Pérez-Grijalba, Inmaculada Monleón, Mercè Boada, Lluís Tárraga

Int J Alzheimers Dis· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytotoxicity of quinone drugs on highly proliferative human leukemia T cells: reactive oxygen species generation and inactive shortened SOD1 isoform implications.
Juan Ignacio Aguiló, María Iturralde, Inmaculada Monleón, Pedro Iñarrea, Julián Pardo

Chem Biol Interact· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma β-amyloid peptides in canine aging and cognitive dysfunction as a model of Alzheimer's disease.
Ángela González-Martínez, Belén Rosado, Pedro Pesini, María-Luisa Suárez, Germán Santamarina

Exp Gerontol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical significance of plasmatic amyloid A{beta}-40 peptide levels in Alzheimer's disease patients treated with galantamine.
Pedro J Modrego, Inmaculada Monleon, Manuel Sarasa

Am J Alzheimers Dis Other Demen· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of Fas/CD95 surface expression in highly proliferative leukemic cell lines correlates with loss of CtBP/BARS and redirection of the protein toward giant lysosomal structures.
Inmaculada Monleón, María Iturralde, María José Martínez-Lorenzo, Luis Monteagudo, Pilar Lasierra

Cell Growth Differ· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis